Serum S‐100β protein is a potential biochemical marker for cerebral oedema complicating severe diabetic ketoacidosis
暂无分享,去创建一个
P. Perros | R. Sherwood | H. Abraha | E. McIntyre | R. Sherwood | Petros Perros | H. D. Abraha | E. A. McIntyre | R. Sherwood
[1] R Malley,et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. , 2001, The New England journal of medicine.
[2] C. Blomstrand,et al. Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. , 1998, Stroke.
[3] C. Alling,et al. The appearance of S-100 protein in serum during and immediately after cardiopulmonary bypass surgery: a possible marker for cerebral injury. , 1997, Journal of cardiothoracic and vascular anesthesia.
[4] J. Garthwaite,et al. Serum S-100 Protein, Relationship to Clinical Outcome in Acute Stroke , 1997, Annals of clinical biochemistry.
[5] S. Silver,et al. Pathogenesis of cerebral edema after treatment of diabetic ketoacidosis. , 1997, Kidney international.
[6] R. Donato. Perspectives in S-100 protein biology. Review article. , 1991, Cell calcium.
[7] A. Rosenbloom. Intracerebral Crises During Treatment of Diabetic Ketoacidosis , 1990, Diabetes Care.
[8] H. Hårdemark,et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. , 1987, Stroke.
[9] D. Hilt,et al. The S 100 protein family , 1988 .